Walleye Trading LLC Horizon Therapeutics Public LTD CO Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$79.4 - $116.36 $1.14 Million - $1.67 Million	-14,383 Reduced 96.63%	502 $40,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $1.05 Million - $1.28 Million	10,668 Added 252.98%	14,885 $1.6 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $376,279 - $451,854	4,094 Added 3328.46%	4,217 $462,000
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $5.49 Million - $6.1 Million	-63,617 Reduced 99.81%	123 $12,000
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $3.05 Million - $4.06 Million	42,475 Added 199.74%	63,740 $5.87 Million

Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $1.07 Million - $1.34 Million	15,907 Added 296.88%	21,265 $1.56 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $136,253 - $196,477	5,358 New	5,358 $194,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.